Contribution: Industrial Research Assistance Program – Contributions to Firms
Syantra Inc.
$237,852.00
Optimization of Breast Cancer Blood-based Diagnostic Test
FY 2018-19 · 2018-05-01
Summary
The project focuses on the clinical evaluation and validation of Syantra’s blood and tissue based breast cancer test. Software development and ICT related optimization, data analysis and reporting will also be finalized to support product's commerical use.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
772728499
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-05-01 | 2018-19 | $237,852.00 |
| 2 | 2018-05-01 | 2018-19 | $237,852.00 |
| 3 | 2018-05-01 | 2018-19 | $237,852.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 152 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 152 jours.
Agreement End Date
2020-03-31
Agreement Number
907317
Agreement Start Date
2018-05-01
Agreement Title
Optimization of Breast Cancer Blood-based Diagnostic Test
Agreement Title (French)
Optimisation du test diagnostique de cancer du sein à base de sang
Agreement Type
Contribution
Agreement Value
$237,852.00
Amendment Date
2019-12-19
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project focuses on the clinical evaluation and validation of Syantra’s blood and tissue based breast cancer test. Software development and ICT related optimization, data analysis and reporting will also be finalized to support product's commerical use.
Description (French)
Le projet met l’accent sur l’évaluation clinique et la validation de sang et de tissus de Syantra en fonction test de dépistage du cancer du sein. Le développement de logiciel et l’optimisation ICT « indirect Coombs test », l’analyse des données et l'établissement de rapport devront également être finalisés pour appuyer l'utilisation commerciale du produit.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
48005
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
772728499
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Syantra Inc.
Recipient Postal Code
T2N 1N4
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2018-2019-Q1-907317
